Results 61 to 70 of about 2,534 (156)

Type I lamellar ichthyosis improved by tazarotene 0.1% gel

open access: yes, 2003
The efficacy of tazarotene 0.1% gel in a 30-year-old woman with type I lamellar ichthyosis is reported. The drug was applied to 15% of the total body surface area as follows: once daily for 2 weeks, three times a week for further 2 weeks, followed by a ...
Bianchi, L   +9 more
core   +1 more source

Combination phototherapy of psoriasis with tazarotene and UVB

open access: yes, 1999
The addition of oral retinoids to phototherapy has shown to enhance both the efficacy and rapidity of psoriatic lesion clearance when compared to phototherapy alone.
PATRONE, Pasquale   +4 more
core   +1 more source

Effectiveness of Topical Tazarotene 0.1% Gel Versus Oral Fluconazole in Treatment    of Onychomycosis

open access: yesPakistan Armed Forces Medical Journal
Objective: The objective of this study was to assess the comparative effectiveness of topical Tazarotene 0.1% gel and weekly oral Fluconazole in the treatment of onychomycosis. Study Design: Comparative prospective study. Place and Duration of Study:
Muhammad Ammar Khan   +5 more
doaj   +1 more source

The Effects and Mechanisms of Pomegranate on Regulating Lipid Metabolism

open access: yesFood Science &Nutrition, Volume 14, Issue 4, April 2026.
This study established a high‐fat diet‐induced hyperlipidemia rat model to investigate the lipid‐lowering effects of pomegranate. Pomegranate intervention significantly reduced serum total cholesterol (TC), triglyceride (TG), and low‐density lipoprotein cholesterol (LDL‐C) levels, while alleviating hepatic steatosis by decreasing liver weight and fat ...
Hao Wang   +9 more
wiley   +1 more source

Periungual pyogenic granulomas due to topical tazarotene for nail psoriasis.

open access: yes, 2014
Tazarotene is a topically-applied, receptor-selective retinoid that has been shown to modulate several major pathogenic factors of psoriasis. Adverse effects are those of topical application of retinoids, the most common being mild to moderate burning ...
PIRACCINI, BIANCA MARIA   +2 more
core   +1 more source

Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults

open access: yesClinical, Cosmetic and Investigational Dermatology, 2020
Vidhatha Reddy,1 Bridget Myers,1 Eric J Yang,2 Tina Bhutani1 1University of California, San Francisco, Department of Dermatology, San Francisco, CA, USA; 2Virginia Mason Medical Center, Seattle, WA, USACorrespondence: Vidhatha ReddyUniversity of ...
Reddy V, Myers B, Yang EJ, Bhutani T
doaj  

Topical therapies in psoriasis

open access: yesIndian Dermatology Online Journal, 2017
Topical therapy as monotherapy is useful in psoriasis patients with mild disease. Topical agents are also used as adjuvant for moderate-to-severe disease who are being concurrently treated with either ultraviolet light or systemic medications. Emollients
R Torsekar, Manjyot M Gautam
doaj   +1 more source

Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate‐to‐Severe Acne

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 4, April 2026.
ABSTRACT Background Acne vulgaris is a common inflammatory skin disorder with significant psychosocial impact. While isotretinoin remains the gold standard for moderate‐to‐severe cases, its adverse effects and teratogenicity underscore the need for alternative systemic therapies.
Nello Tommasino   +3 more
wiley   +1 more source

Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention

open access: yesFrontiers in Immunology, 2018
Chemerin [RARRES2 [retinoic acid receptor responder 2], TIG2 [tazarotene induced gene 2 (TIG2)]] is a multifunctional cytokine initially described in skin cultures upon exposure to the synthetic retinoid tazarotene. Its secreted pro-form, prochemerin, is
Woo Jae Shin   +3 more
doaj   +1 more source

Advances in Bioprinting to Model Immune‐Mediated Skin Diseases

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 9, 6 March 2026.
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy